BLFS
BioLife SolutionsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Composite grade A from latest DB weights. Momentum 81.7 / Value 48.5
Posture
Constructive
Lead driver
Momentum
What changed
1 setup hits (3d) with net bullish as of 2026-06-02.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
82
Value
49
Sentiment
N/A
Setup hits (3d)
1 · Net Bullish
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Bullish
Target $32.40
Why
Momentum82 · Δ7d +19.1
Value49 · Δ7d +0.1
SentimentN/A · Δ7d -
So what
Strength-led posture (Net Bullish). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
82
52% active weight
Current posture
7d trendImproving
Δ7d
+19.1
Δ21d
+35.5
Value
49
48% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.3
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 81.7 / Value 48.5
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$1.3B
Beta
1.93
Shares Out
48.15M
P/E (TTM) · Derived
-86.5
P/S (TTM)
13.72
P/FCF (TTM)
3795.89
Rev YoY
+31.2%
EPS YoY
+225.0%
Gross Margin
+70.0%
Op Margin
-18.6%
Net Debt
-$88.64M
Current Ratio
4.66
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology